Restoring the natural balance to the immune system to treat autoimmune diseases.

Autoimmunity BioSolutions is developing immunomodulatory therapies targeting soluble IL7R (sIL7R) to restore immune system homeostasis by reducing autoreactive T-cell expansion. Their initial therapeutic focus is on genetically defined patient groups in multiple sclerosis and lupus nephritis, with potential application in other autoimmune conditions.